How this list was built
Strain names are not standardized. Two batches sold under the same name can test at different cannabinoid levels. This comparison uses three inputs: published lab reports, CBD to THC ratio, and the strength of clinical evidence for that ratio. Ratio predicts effect better than name does. A 2017 report from the National Academies of Sciences, Engineering, and Medicine found substantial evidence that cannabis reduces chronic pain in adults. NIH-indexed reviews put the average effect size at small to moderate. The FDA has not approved cannabis flower for chronic pain. Three cannabinoid drugs carry FDA approval: Epidiolex, dronabinol, and nabilone.
Optimizing Medical Cannabis Dosage for Chronic Pain
Pick first: ACDC
ACDC is a sativa-dominant phenotype of Cannatonic. Published lab reports list CBD between 15% and 20% and THC between 0.5% and 1.1%. That is a CBD to THC ratio near 20:1. High-CBD, low-THC material produces little intoxication at common doses. It suits people who need daytime pain control and cannot be impaired at work. Reported effects include less nerve pain and less muscle spasm.
medical marijuana for chronic pain
The other four options
2. Harlequin
Harlequin runs a CBD to THC ratio near 5:2. Lab reports list CBD at 8% to 10% and THC at 4% to 6%. The THC level is high enough to produce mild psychoactivity. Some patients use it for inflammatory joint pain and migraine. Onset after inhalation is 2 to 10 minutes. Duration is 1 to 3 hours.
Medical Marijuana for Chronic Pain: A Comprehensive Guide
3. Cannatonic
Cannatonic tests between 1:1 and 2:1 CBD to THC depending on phenotype. CBD lands near 6% to 17%. THC ranges from 0.5% to 6%. The spread is wide, so the batch certificate matters more than the label. A 1:1 ratio suits evening use and sleep onset.
4. Northern Lights
Northern Lights is an indica with THC at 16% to 21% and CBD under 1%. Evidence for high-THC flower in chronic pain is weaker than for balanced ratios. Side effects include short-term memory problems, dry mouth, and impaired coordination. The CDC lists those effects in its cannabis health summary. Start with 1 mg to 2 mg THC for a first trial.
5. Charlotte's Web
Charlotte's Web is a hemp cultivar with THC under 0.3% and CBD at 10% to 20%. It is legal as a hemp product in the United States under the 2018 Farm Bill. Pain evidence for CBD alone is thinner than for THC-CBD combinations. Reviews of CBD for chronic pain report mixed results and small sample sizes.
Comparison at a glance
- ACDC: 20:1 CBD to THC, daytime, low impairment
- Harlequin: 5:2 CBD to THC, daytime to evening, mild impairment
- Cannatonic: 1:1 to 2:1, evening, moderate impairment
- Northern Lights: THC dominant, night, high impairment
- Charlotte's Web: THC under 0.3%, daytime, no impairment at label doses
What to check before buying
- Ask for a batch certificate with cannabinoid levels from an ISO 17025 lab.
- Confirm total THC, not just delta-9 THC. THCA converts on heating.
- Note the harvest date. THC degrades to CBN over 12 to 18 months.
- Track dose in milligrams, not puffs. Effects differ by route.
If THC is illegal in your state
Federal law sets the hemp THC limit at 0.3% on a dry weight basis. CBD products sold across state lines must stay under that line. A lab-tested CBD tincture delivers a measured milligram dose and no intoxicating THC. That is the practical option where medical cannabis programs do not cover pain.